Prognostic and clinical significance of modified glasgow prognostic score in pancreatic cancer: a meta-analysis of 4,629 patients

Dongdong Wu; Xingmu Wang; Ge Shi; Honggang Sun; Guoxing Ge

doi:doi:10.18632/aging.202357

← Back

Research Paper Volume 13, Issue 1 pp 1410—1421

Prognostic and clinical significance of modified glasgow prognostic score in pancreatic cancer: a meta-analysis of 4,629 patients

Figure 3. The association between mGPS and clinical factors in pancreatic cancer. (A) mGPS and sex (male vs female); (B) mGPS and tumor location (head vs body/tail).